Melatonin Supplementation in Iranian Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Exploring Oxidative Stress and Inflammation
International Journal of Preventive Medicine · 2026-02 · 17
DOI: 10.4103/ijpvm.ijpvm_72_24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Preventive Medicine, 2026-02. Verfasst von Seyed Sobhan Bahreiny und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Diabetes mellitus is a global health challenge characterized by oxidative stress (OS) and persistent inflammation, which contribute to the progression of complications. Melatonin, a multifaceted hormone known for its potent antioxidant and anti-inflammatory properties, has emerged as a potential therapeutic intervention in diabetes. This systematic review and meta-analysis aimed to evaluate the effects of melatonin supplementation on crucial biomarkers of OS (malondialdehyde (MDA), total antioxidant capacity (TAC), glutathione (GSH)) and inflammation (C-reactive protein (CRP)) in Iranian diabetic patients.
Methods
A thorough literature search was conducted until August 2023 in MEDLINE (PubMed), Embase, Web of Science, Cochrane Central, Magiran, and Scopus databases using keywords corresponding to MeSH, such as “diabetes,” “melatonin,” “oxidative stress,” “randomized clinical trial,” and “Iranians.” The study focused on eight randomized controlled trials conducted on diabetic patients in Iran. The data were analyzed using the random-effects model, and the summary effect size was determined using the standardized mean difference (SMD).
Results
Our research indicates that melatonin supplementation led to significant reductions in CRP levels (SMD) = −1.74; 95% confidence interval (CI): −2.79, −0.69; P = 0.001) and MDA levels (SMD = −1.35; 95% CI: −2.17, −0.53; P = 0.001). Furthermore, the study found an increase in TAC levels (SMD = 2.79; 95% CI: 0.54, 5.04; P = 0.0006) and GSH levels (SMD = 1.86; 95% CI: 0.80, 2.93; P = 0.0006) following melatonin supplementation. In addition, subgroup analysis revealed that a lower dosage of 3–6 mg/day resulted in more pronounced effects, with a statistically significant difference observed in MDA reduction compared to higher doses.
Conclusions
Melatonin supplementation is a promising complementary strategy to attenuate OS and inflammation in diabetic patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Physiology, Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Zitieren
APA
Bahreiny, S. S., Mohammadpour Fard, R., Ahangarpour, A., Kazemzadeh, R., Rashno, M., Dabbagh, M. R., Radan, M., & Hoseinynejad, K. (2026). Melatonin Supplementation in Iranian Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Exploring Oxidative Stress and Inflammation. International Journal of Preventive Medicine, 17. https://doi.org/10.4103/ijpvm.ijpvm_72_24
Vancouver
Bahreiny SS, Mohammadpour Fard R, Ahangarpour A, Kazemzadeh R, Rashno M, Dabbagh MR, et al. Melatonin Supplementation in Iranian Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Exploring Oxidative Stress and Inflammation. International Journal of Preventive Medicine. 2026;17. doi:10.4103/ijpvm.ijpvm_72_24
BibTeX
@article{Bahreiny2026,
author = {Bahreiny, Seyed Sobhan and Mohammadpour Fard, Reza and Ahangarpour, Akram and Kazemzadeh, Razieh and Rashno, Mohammad and Dabbagh, Mohammad Reza and Radan, Maryam and Hoseinynejad, Khojasteh},
title = {Melatonin Supplementation in Iranian Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Exploring Oxidative Stress and Inflammation},
journal = {International Journal of Preventive Medicine},
year = {2026},
volume = {17},
doi = {10.4103/ijpvm.ijpvm_72_24}
}
EUVIMED